Mohammad Ghofrani
Overview
Explore the profile of Mohammad Ghofrani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasehi M, Ghofrani M, Tabrizi A, Abdollah Gorji F, Khosravi B
Iran J Child Neurol
. 2022 Oct;
16(3):167-182.
PMID: 36204433
Objectives: To determine the effectiveness of Rituximab (RTX) therapy as the first therapeutic choice for the long-term prevention of secondary relapse in children with AIND that had relapse after primary...
2.
Zarrabi M, Ghahvechi Akbari M, Amanat M, Majmaa A, Moaiedi A, Montazerlotfelahi H, et al.
BMC Neurol
. 2022 Mar;
22(1):123.
PMID: 35351020
Introduction: The current multi-center, randomized, double-blind study was conducted among children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood mononuclear cell (UCB-MNC). We performed...
3.
Tonekaboni S, Mahmoudi S, Abdollah Gorji F, Nejad Biglari H, Taghdiri M, Etemadi K, et al.
Iran J Child Neurol
. 2021 Nov;
15(4):27-34.
PMID: 34782839
Objective: Guillain-Barré Syndrome (GBS) is an acute inflammatory polyneuropathy characterized by a rapid progressive symmetric weakness. The GBS is the most common cause of acute flaccid paralysis (AFP) in most...
4.
Karimzadeh P, Ghofrani M, Nasiri S
Iran J Child Neurol
. 2020 Sep;
14(3):19-32.
PMID: 32952579
Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at...
5.
Ghofrani M, Tonekaboni H, Karimzadeh P, Nasiri J, Pirzadeh Z, Ghazzavi M, et al.
Int J Prev Med
. 2018 Sep;
9:69.
PMID: 30167099
Background: Considering that better understanding of the underlying mechanisms and risk factors of arterial ischemic stroke (AIS) would be helpful for better management of stroke and its outcome in children...
6.
Ghofrani M, Nasehi M, Saket S, Mollamohammadi M, Taghdiri M, Karimzadeh P, et al.
Iran J Child Neurol
. 2018 Jul;
12(3):94-100.
PMID: 30026773
Objective: This study was conducted to predict the response to treatment in patients treated with anti-epilepsy drugs. Material And Methods: This analytical questionnaire-based study was conducted in 2014 among 128...
7.
Nasehi M, Sahraian M, Naser Moghadasi A, Ghofrani M, Ashtari F, Taghdiri M, et al.
Iran J Child Neurol
. 2017 Jul;
11(2):37-43.
PMID: 28698726
Objective: Overall, 2%-5% of patients with multiple sclerosis (MS) experienced the first episode of disease before the age 18 years old. Since the age of onset among children is not...
8.
Pirzadeh Z, Ghofrani M, Mollamohammadi M
Iran J Child Neurol
. 2017 Jul;
11(2):31-36.
PMID: 28698725
Objective: Intractable epilepsy is a serious neurologic problem with different etiologies. Decreased levels of pyridoxal phosphate in cerebral spinal fluid of patients with intractable epilepsy due to pyridoxine dependency epilepsy...
9.
Ghofrani M, Yahyaei M, Brunner H, Cremers F, Movasat M, Khan M, et al.
Iran Biomed J
. 2017 May;
21(5):294-302.
PMID: 28460491
Background: Inherited retinal diseases (IRDs) are a group of genetic disorders with high degrees of clinical, genetic and allelic heterogeneity. IRDs generally show progressive retinal cell death resulting in gradual...
10.
Karimzadeh P, Kakhki S, Esmail Nejad S, Houshmand M, Ghofrani M
Iran J Child Neurol
. 2017 Mar;
11(1):78-81.
PMID: 28277561
Although AOA1 (ataxia oculomotor apraxia1) is one of the most common causes of autosomal recessive cerebellar ataxias in Japanese population, it is reported from all over the world. The clinical...